Literature DB >> 33391959

Warfarin-Induced Calciphylaxis in a COVID-19 Patient.

Fatima H Abutaki1, Dunya Alfaraj1, Abdullah Alshahrani1, Tarek Elsharkawy2.   

Abstract

Calciphylaxis is a rare but highly fatal vascular calcification disorder with a predilection for patients with end stage renal disease (ESRD). The pathogenesis of calciphylaxis is unknown, however, several risk factors have been identified such as hypercalcemia, hyperphosphatemia, hyperparathyroidism, low serum albumin, and history of warfarin therapy. This article presents a case of calciphylaxis induced by warfarin in a COVID-19 patient.
Copyright © 2020, Abutaki et al.

Entities:  

Keywords:  calcific uremic arteriolopathy; calciphylaxis; covid-19; esrd; hypercoagulability; skin necrosis; warfarin

Year:  2020        PMID: 33391959      PMCID: PMC7767840          DOI: 10.7759/cureus.12249

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  2 in total

1.  Nonuremic calciphylaxis in a COVID-19 patient.

Authors:  Natasha Mathur; Robert F Duffy; Brandyn Chinn; Miles M McFarland; Brian P Gable; Christina M Clay; Warren R Heymann
Journal:  Int J Dermatol       Date:  2021-05-17       Impact factor: 3.204

2.  Nonuremic Calciphylaxis Precipitated by COVID-19 Infection.

Authors:  Hannah Shuman; Mark S Obri; Christina Artz; Raef Fadel; Jonathan Williams
Journal:  Cureus       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.